Research articles
ScienceAsia 45 (2019): 221-228 |doi:
10.2306/scienceasia1513-1874.2019.45.221
Antimalarial and β-hematin formation inhibitory
activities of chromone derivatives
Chirattikan Maicheena, Jiraporn Ungwitayatornb,*
ABSTRACT: A series of chromone compounds were evaluated as new potential antimalarial agents using in vitro
antimalarial activity assay. The most potent compound 36 with an IC50 of 0.95 μM was shown to be more potent
than primaquine and tafenoquine (IC50 2.41 and 1.95 μM, respectively). β-Hematin formation inhibitory activity test
and stoichiometry determination have also been performed to investigate the preliminary mechanism of antimalarial
activity of the studied compounds. Compounds 23-28 (IC50 1.41, 1.76, 2.30, 2.54, 4.60, and 3.69 μM, respectively)
displayed greater β-hematin formation inhibitory activity than chloroquine, dihydroartemisinin, and mefloquine (IC50
25.04, 18.04, 15.78 μM, respectively). Compounds 3, 4, 23, 24, 27, 36, 38, and 43 showed high potency in both
antimalarial and β-hematin formation assays. Job's plots indicated that compounds showing high β-hematin formation
inhibitory activity formed stable complexes with the same stoichiometric ratio of chromone:heme = 1:2 as chloroquine.
This study opens up the possibility of development of chromone derivatives as new antimalarials targeting β-hematin
formation.
Download PDF
159 Downloads 1307 Views
| a |
Faculty of Pharmacy, Huachiew Chalermprakiet University, Samut Prakarn 10540 Thailand |
| b |
Faculty of Pharmacy, Mahidol University, Bangkok 10400 Thailand |
* Corresponding author, E-mail: jiraporn.ung@mahidol.ac.th
Received 5 Feb 2019, Accepted 24 May 2019
|
